Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response

Journal of Immunology

Volumn 156, Issue 4, 1996, Pages 1349-1355

  Dong, Rui Ping ^a   Kameoka, Junichi ^a   Hegen, Martin ^a   Tanaka, Toshiaki ^a   Xu, Yuhui ^a,b   Schlossman, Stuart F ^a   Morimoto, Chikao ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE;

ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE;

ADENOSINE; ADENOSINE DEAMINASE; ANTIGENS, CD26; EXTRACELLULAR SPACE; HUMANS; INTERLEUKIN-2; PROTEIN BINDING; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0030045246     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Fox, D A., R E Hussey, K. A. Fitzgerald, O Acuto, C. Poole, L Palley, J F Daley, S. F Schlossman, and E. L. Reinherz 1984. Tal. a novel 105 kD human T cell activation antigen defined by a monoclonal antibody. J. Immunol. 133 1250.
2. Fleischer, B. 1987 A novel pathway of human T cell activation via a 103 kD T cell activation antigen J. Immunol. 138:1346
3. Morimoto, C., Y. Torimoto, G. Levinson, C. E Rudd, M. Schrieber, N. H. Dang, N L Letvin, and S. F. Schlossman. 1989. 1F7, a novel cell surface molecule involved in helper function of CD4 cells J. Immunol. 143:3430.
4. Hegen, M., G. Niedobitek, C. E Klein, H. Stein, and B. Fleischer. 1990. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J. Immunol 144:2908
5. Ulmer, A. J , T Mattern, A. C, Feller, E Heymann, and H. Flad 1990. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4ELIC7. Scand. J. Immunol 31 429.
6. Morimoto, C., and S F. Schlossman. 1994. CD26, a key costimulatory molecule on CD4 memory T cells. Immunologist 2:4
7. Fleischer, B. 1994. CD26: a surface protease involved in T-cell activation Immunol. Today 15:180
8. Yaron, A., and F. Naider. 1993. Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem. Mol. Biol. 28:31
9. Dang, N. H , D. A. Hafler, S. F Schlossman, and J. B. Breitmeyer. 1990. FcR-mediated crosslinking of Tal (CDw26) induces human T lymphocyte activation. Cell Immunol 125:42.
10. Dang, N H , Y. Torimoto, K. Deusch, S. F. Schlossman, and C. Morimoto. 1990. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J. Immunol. 144:4092.
11. Dang, N. H, Y Torimoto, S. F. Schlossman, and C. Morimoto 1990. Human CD4 helper T cell activation, functional involvement of two distinct collagen receptors, 1F7 and VAL intergrin family. J. Exp Med. 172:649.
12. Tanaka, T., J. Kameoka, A. Yaron, S. F. Schlossman, and C. Morimoto. 1993. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc. Natl. Acad. Sci USA 90:4586
13. Tanaka, T. J. S Duke-Cohan, J Kameoka, A Yaron, I Lee, S. F Schlossman, and C. Morimoto. 1994. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeplidyl peptidase IV. Proc. Natl Acad. Sci. USA 91 3082.
14. Tanaka, T , D. Camerini, B. Seed, Y. Torimoto, N. H. Dang, J Kameoka, H. N. Dahlberg, S F. Schlossman, and C Morimoto. 1992. Cloning and functional expression of the T cell activation antigen, CD26. J Immunol 149:481
15. Torimoto, T., N. H. Dang, E. Vivier, T. Tanaka, S. F. Schlossman, and C. Morimoto. 1991. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes J. Immunol. 147:2514
16. Kameoka, J., T. Tanaka, Y Nojima, S. F. Schlossman, and C. Morimoto 1993. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261:466.
17. Murray, J. L., R Pérez-Soler, D Bywaters, and E. M. Hersh. 1986. Decreased adenosine deaminase and 5′-nucleotidase activity in peripheral blood T cells in Hodgkin disease. Am. J Hematol 21:57.
18. Vives-Corrons, J. L., C. Rozman, M. A, Pujades, D. Colomer, E. Perez-Vila, I. Anegon, T. Gallart, J. Vives-Puiggros, N. Viñolas, and E. Montserrat. 1988. Combined assay of adenosine deaminase, purine nucleoside phosphorylase, and lactate dehydrogenase in the early clinical evaluation of B-chronic lymphocytic leukemia. Am J. Hematol. 27:157.
19. Vezzoni, P, F. Fiacchino, L. Clerici, A. Sghirlanzoni, D. Cerrato, D. Peluchetti, R. Luchini, M. Raineri, and F Cornelio. 1984. Studies on terminal deoxynucleotidyl transferase and adenosine deaminase in myasthenic thymus J. Neuroimmunol. 6:427.
20. Murray, J. L., K. C. Loftin, C G. Munn, J. M. Reuben, P. W. A. Mansell, and E. M. Hersh. 1985. Elevated adenosine deaminase and purine nucleotide phosphorylase in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome Blood 65:1318.
21. Hirschhorn, R. 1990 Adenosine deaminase deficiency. In Immunodeficiency Reviews, Vol. 2. F. S. Rosen and M. Seligmann, eds. Howard, London, p. 175
22. Morrison, M. E., S Vijayasaradhi. D. Engelstein, A. P. Albino, and A, N. Houghton. 1993. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J. Exp Med. 177:1135.
23. Meester, I. D , G. Vanham, L. Kestens, G. Vanhoof, E Bosmans, P. Gigase, and S. Scharpe 1994. Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur. J. Immunol. 24:566.
24. Daddona, P E, D. S. Shewach, W. N. Kelley, P Argos, A. F. Markham, and S. H. Orkin 1984. Human adenosine deaminase: cDNA and complete primary ammo acid sequence. J. Biol. Chem. 259:12101
25. Rubartelli, A., F Cozzolino, M. Talio, and R. Sitia. 1990 A novel secretary pathway for interleukin 1-beta, a protein lacking a signal sequence EMBO J 9:1503.
26. Kandel, J., E. Bossy-Wetzed, F. Radvanyi, M. Klagsbrun, J Folkman, and D. Hanahan. 1991. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095.
27. Alt, H. W., G D Yancopoulos, T. K. Blackwell, C. Wood, E. Thomas, M. Boss, R. Cottman, N. Rosenberg, S. Tonegawa, and D Baltimore 1984. Ordered rearrangement of immunoglobulin heavy chain variable region segments EMBO J 3:1209
28. Kohn, D. B., H. Mitsuya, M. Ballow, J. E. Selegue, J. Barankiewicz, A Cohen, E. Gelfand, W. F. Anderson, and R. M Blaese 1989. Establishment and characterization of adenosine deaminase-deficient human T cell lines. J. Immunol. 142:3971.
29. Moore, K. A., F. A. Fletcher, D. K. Villalon, A. E. Utter, and J. W. Belmont. 1990. Human adenosine deaminase expression in mice. Blood 75:2085.
30. Torimoto, Y., N. H. Dang, T. Tanaka, C Prado. S. F Schlossman, and C. Morimoto. 1992. Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Mol. Immunol. 29:183.
31. de Agostini, A. I., S. W Watkins, H S. Slayter, H. Youssoufian, and R D Rosenberg. 1990. Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium, antithrombin binding on cultured endothelial cells and perfused rat aorta. J. Cell Biol. 111:1293.
32. Watkins, S. W., V. Raso, and H. S. Slayter 1990 Immunoelectron-microscopic studies of human platelet thrombospondin, Von Willebrand factor, and fibrinogen redistribution during clot formation. Histochem. J. 22:507.
33. Dinjens, W. N. M., J. ten Kate, J. T. Wijnen, E. P. M. van der Linden, C. J. L. Beek, M.-H. J. H Lenders, P. M. Khan, and F. T. Bosman. 1989 Distribution of adenosine deaminase-complexing protein in murine tissues. J. Biol. Chem. 264: 19215.
34. Schrader, W. P., C. A. West, A. D Miczek, and E. K. Norton. 1990 Characterization of the adenosine deaminase-adenosine deaminase complexing protein binding reaction. J. Biol. Chem. 265:19312.
35. Giblett, E R., J. E Anderson, F. Cohen, B. Pollara, and H. J. Meuwissen. 1972. Adenosme deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067.
36. Mitchell, B. S., E. Mejias, P. E. Daddona, and W. N. Kelley 1978. Purogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells Proc. Natl Acad. Sci. USA 75:5011
37. Wakamiya, M., M. R. Blackburn, R. Jurecic, M. J McArthur, R. S. Geske, J. Cartwright, Jr., K. Matani, S. Vaishnav, J W. Belmont, R. E Kellems, M J. Finegold, C. A. Montgomery, Jr., A. Bradley, and C. T. Caskey. 1995. Disruption of the adenosine deaminase gene causes hapatocellular impairment and perinatal lethality in mice. Proc. Natl. Acad. Sci USA 92:3673.
38. Martin, M., J. J. Centelles, J. Huguet, F. Echevarne, D Colomer, J. L. Vives-Corrons, and R. Franco. 1993. Surface expression of adenosine deaminase in mitogen-stimulated lymphocytes Clin. Exp. Immunol. 93:286.
39. Olsson, R. A., and J. D Pearson. 1990 Cardiovascular purinoceptors. Physiol. Rev. 70:761.
40. Stiles, G. L. 1992. Adenosine receptors. J. Biol Chem. 267:6451.
41. Smith, I. W., A. L Steiner, and C. W. Parker. 1971. Human lymphocyte metabolism: effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J. Clin. Invest. 50:442.
42. Green, H , and T.-S. Chan. 1973. Pyrimidine starvation induced by adenosine in fibroblasts and lymphoid cells: role of adenosine deaminase. Science 182:836.
43. Carson, D. A , and J. E. Seegmiller. 1976. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. J. Clin. Invest. 57:274.
44. Hovi, T., J. F Smyth, A. C. Allison, and S. C. Williams. 1976. Role of adenosine deaminase in lymphocyte proliferation. Clin. Exp. Immunol. 23:395
45. Ruers, T J. M , W. A. Buurman, and C. J van der Linden. 1987 2′-Deoxyconformycin and deoxyadenosine affect IL-2 production and IL-2 receptor expression of human T cells J. Immunol. 138:116.
46. Buc, H A, A Moncion, M. Hamet, A -M. Houllier, L. Thuiller, and J.-L Perignon. 1990. Influence of adenosine deaminase inhibition on the phosphoinositide turnover in the initial stages of human T cell activation. Eur. J. Immunol. 20:611.
47. Kizaki, H , H. Shimada, F Ohsaka, and T. Sakurada 1988 Adenosine, deoxyadenosine and deoxyguadenosine induce DNA cleavage in mouse thymocytes. J. Immunol 141:1652.
48. Seto, S , C J. Carrera, M. Kubota, D. B. Wasson, and D. A. Carson. 1985 Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J. Clin. Invest. 75:377
49. 2+-mediated mechanisms. Biochem. J. 304:877.
50. Dang, N. H , Y. Torimoto, K. Shimamura, T. Tanaka, J F. Daley, S. F Schlossman, and C. Morimoto. 1991. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J. Immunol. 147:2825.
51. Mackenzie, W. M., D. W Hoskin, and J. Blay. 1994. Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor. Cancer Res 54:3521.
52. Kraut, E. H., M R. Grever, and B. A Bouroncle 1994. Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood. 84:4061.
53. Ellison, D. J., R W. Sharpe, B. A. Robbins, J. C. Leopard, A. Saven, and L. D. Piro 1994 Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia Blood 84:4310.
54. Martin, M , J. M. Aran, D. Colomer, J Huguet, J J. Centelles, J. L. Vives-Corrons, and R. Franco 1994 Surface adenosine deaminase a novel B-cell marker in chronic lymphocytic leukemia. Hum Immunol. 42:265.
55. Masuyama, J., J S. Berman, W W. Cruikshank, C. Morimoto, and D. M. Center. 1992 Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro J Immunol. 148:1367.
56. Hafler, D A., D. A Fox, M. E. Manning, S F. Schlossman, E L. Reinherz, and H L Weiner. 1985. in vitro activation T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N. Engl. J Med. 312:1405.
57. Nakao, H., K. Eguchi, A Kawakami, K. Migita, T Otsubo, Y. Ueki, C. Shimomura, H. Tezuka, M. Matsunaga, K. Maeda, and S Nagataki. 1989. Increment of Tal positive cells in peripheral blood from patients with rheumatoid arthritis. J. Rheumatol. 16:904
58. + cells in the peripheral blood and thyroid tissue of patients with Graves' disease J. Immunol 142:4233
59. Cronstein, B N., D. Naime, and E Olstead. 1993 The antiinflammatory mechanism of methotrexate: increased adenosine release at inflamed site diminishes leukocyte accumulation-an in vivo model of inflammation J Clin. Invest. 92:2675